TNFA (TNF Pharmaceuticals Inc.) Market Value to Book Value Ratio

TNF Pharmaceuticals is implementing bioinformatics platforms for digital protein modeling to optimize drug design. The history of the market valuation relative to book value demonstrates investor confidence, with 0.30 representing the latest metric reading. The company is deploying software robots for clinical data analysis while simultaneously transitioning to closed-loop water systems to minimize its environmental footprint during production.

TNFA tnfpharma.com: Market Value to Book Value in the range 07/25/2024 - 09/25/2025

Financial and market metric breakdowns for TNF Pharmaceuticals (TNFA)

- price and consensus price forecast:
Stock Price tnfpharma.com|TNFA - Analyst Consensus Forecast
- market capitalization data:
Market Value TNF Pharma|TNFA - Full Business Value
- book capitalization data:
Book Value per Share TNF Pharmaceuticals|TNFA - Accounting Value of Company|Market Capitalization to Book Value Ratio tnfpharma.com|TNFA - Company Total Assets
- debt and liquidity data:
Debt to Equity TNF Pharmaceuticals|TNFA - Long-Term Debt to Capital Coefficient|Short-Term Debt to Equity tnfpharma.com|TNFA - Company Total Debt|Debts to Book Capitalization TNF Pharma|TNFA - Company Long-Term Debts|Company Current Liabilities TNF Pharmaceuticals
Initial company analysis:TNF Pharmaceuticals Inc. - TNFA

For TNF Pharmaceuticals (TNFA), this ratio reflects the market valuation of assets during the molecule validation period via B2B partnerships. The metric compares the company's current market value with its net book value to measure the investment premium. The price-to-book (P/BV) trend demonstrates the extent to which the market is willing to pay a premium for the future potential of the pipeline. Sharp deviations in this indicator signal either speculative overheating or undervaluation, allowing for an assessment of capitalization stability relative to the issuer's tangible assets.

Main competitors

HLN: Market Capitalization to Book Value Ratio|KVUE (kenvue.com) - Market Capitalization to Book Value Ratio|Market Value to Book Value Ratio Verona Pharma VRNA|Market Capitalization to Net Assets Jyong Biotech Limited|Ligand Pharma (LGND) - Market Capitalization to Book Value Ratio|Market Value to Book Value Amneal Corp (AMRX)|Market Capitalization to Book Value Ratio PRGO (Perrigo Company plc)|alvotech.com - Market Capitalization to Book Value Ratio|Market Value to Book Value Ratio Liquidia (LQDA)|GLPG: Market Value to Book Value|ANIP (ANI Pharma) - Market Value to Book Value Ratio|Afrezza (MNKD) - Market Cap to Net Assets Ratio|AMPH (Amphastar Pharmaceuticals) - Market Capitalization to Book Value Ratio|Market Capitalization to Book Value Ratio pacira.com (PCRX)|ARS Pharmaceuticals, Inc. (SPRY) - Market Cap to Net Assets Ratio|Market Value to Book Value TBPH (Theravance Biopharma Inc)|AQST: Market Value to Book Value Ratio|SCPH - Market-to-Book Ratio|Market Cap to Net Assets Ratio Tectonic TECX|TNXP - Market Cap to Book Value Multiple|Market Capitalization to Book Value Ratio sxtchina.com SXTC|Eupraxia Pharmaceuticals Inc. (EPRX) - Market Value to Book Value|Market Capitalization to Book Value Ratio BHST (BioHarvest)|Market-to-Book Ratio EXOZ|Oramed Pharmaceuticals (ORMP) - Market Value to Book Value Ratio|Market Value to Book Value enterabio.com ENTX|Market Cap to Net Assets Ratio MindWalk Holdings Inc. (HYFT)|ABVC BioPharma Inc. - Market Cap to Book Value Multiple|Cumberland Pharma (CPIX) - Market Value to Book Value Ratio|QNTM - Capitalization to Book Value Ratio|Market Capitalization to Book Value Ratio FibroGen, Inc. (FGEN)|Market Capitalization to Net Assets telomirpharma.com|RANI - Market Cap to Net Assets Ratio|Market Value to Book Value SNYR|RLYB - Market Value to Book Value Ratio|Market Capitalization to Net Assets lexariabioscience.com (LEXX)|Market Capitalization to Book Value Ratio Pulmatrix, Inc.|Market Value to Book Value Pheton Holdings Limited PTHL|Aptorum - Market Capitalization to Book Value Ratio|LYRA: Market Capitalization to Book Value Ratio|Market Value to Book Value Ratio Impact BioMedical IBO|YCBD (cbdMD) - Market Value to Book Value|Market Value to Book Value Ratio PRFX|Market Cap to Net Assets Ratio Auris Medical|Market Capitalization to Book Value Ratio LIPO|Market Capitalization to Book Value Ratio OptiNose Inc (OPTN)|Pieris - Market Capitalization to Book Value Ratio|Market Cap to Net Assets Ratio Procaps Group Corp PROC|PTPI (Petros Pharmaceuticals) - Market Capitalization to Book Value Ratio|qlsyy.net (QLI) - Market-to-Book Ratio|SLRN: Market Cap to Net Assets Ratio|Market Capitalization to Book Value Ratio TFF Pharmaceuticals Inc.